| Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7 P Wang, MS Nair, L Liu, S Iketani, Y Luo, Y Guo, M Wang, J Yu, B Zhang, ... Nature 593 (7857), 130-135, 2021 | 2252 | 2021 |
| COVID-19 vaccine BNT162b1 elicits human antibody and TH 1 T cell responses U Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ... Nature 586 (7830), 594-599, 2020 | 1853 | 2020 |
| REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19 DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, ... New England Journal of Medicine 384 (3), 238-251, 2021 | 1748 | 2021 |
| Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies A Baum, BO Fulton, E Wloga, R Copin, KE Pascal, V Russo, S Giordano, ... Science 369 (6506), 1014-1018, 2020 | 1311 | 2020 |
| Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant L Yurkovetskiy, X Wang, KE Pascal, C Tompkins-Tinch, T Nyalile, Y Wang, ... bioRxiv, 2020 | 1030 | 2020 |
| CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis JD Gillmore, E Gane, J Taubel, J Kao, M Fontana, ML Maitland, J Seitzer, ... New England Journal of Medicine 385 (6), 493-502, 2021 | 1025 | 2021 |
| Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail J Hansen, A Baum, KE Pascal, V Russo, S Giordano, E Wloga, BO Fulton, ... Science 369 (6506), 1010-1014, 2020 | 978 | 2020 |
| BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans U Sahin, A Muik, I Vogler, E Derhovanessian, LM Kranz, M Vormehr, ... Nature 595 (7868), 572-577, 2021 | 635 | 2021 |
| REGEN-COV antibody combination and outcomes in outpatients with Covid-19 DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, J Xiao, ... New England Journal of Medicine 385 (23), e81, 2021 | 612 | 2021 |
| REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters A Baum, D Ajithdoss, R Copin, A Zhou, K Lanza, N Negron, M Ni, Y Wei, ... Science 370 (6520), 1110-1115, 2020 | 566 | 2020 |
| Subcutaneous REGEN-COV antibody combination to prevent Covid-19 MP O’Brien, E Forleo-Neto, BJ Musser, F Isa, KC Chan, N Sarkar, KJ Bar, ... New England Journal of Medicine 385 (13), 1184-1195, 2021 | 452 | 2021 |
| Pre-and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection KE Pascal, CM Coleman, AO Mujica, V Kamat, A Badithe, J Fairhurst, ... Proceedings of the National Academy of Sciences 112 (28), 8738-8743, 2015 | 244 | 2015 |
| Fbxw7α-and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma L Busino, SE Millman, L Scotto, CA Kyratsous, V Basrur, O O’Connor, ... Nature cell biology 14 (4), 375-385, 2012 | 195 | 2012 |
| Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection EO Saphire, SL Schendel, ML Fusco, K Gangavarapu, BM Gunn, AZ Wec, ... Cell 174 (4), 938-952. e13, 2018 | 191 | 2018 |
| The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies R Copin, A Baum, E Wloga, KE Pascal, S Giordano, BO Fulton, A Zhou, ... Cell 184 (15), 3949-3961. e11, 2021 | 190 | 2021 |
| Control of the C. albicans cell wall damage response by transcriptional regulator Cas5 VM Bruno, S Kalachikov, R Subaran, CJ Nobile, C Kyratsous, AP Mitchell PLoS pathogens 2 (3), e21, 2006 | 186 | 2006 |
| BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans U Sahin, A Muik, I Vogler, E Derhovanessian, LM Kranz, M Vormehr, ... MedRxiv, 2020.12. 09.20245175, 2020 | 183 | 2020 |
| Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets DK Singh, B Singh, SR Ganatra, M Gazi, J Cole, R Thippeshappa, ... Nature microbiology 6 (1), 73-86, 2021 | 172 | 2021 |
| Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets DK Singh, B Singh, SR Ganatra, M Gazi, J Cole, R Thippeshappa, ... Nature microbiology 6 (1), 73-86, 2021 | 172 | 2021 |
| Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates KE Pascal, D Dudgeon, JC Trefry, M Anantpadma, Y Sakurai, CD Murin, ... The Journal of infectious diseases 218 (suppl_5), S612-S626, 2018 | 159 | 2018 |
